Technology
Health
Pharmaceutical

Y-mAbs

$22.55
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.23 (-1.01%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Y-mAbs and other stocks, options, ETFs, and crypto commission-free!

About YMAB

Y-mAbs Therapeutics, Inc. Common Stock, also called Y-mAbs, is a clinical-stage biopharmaceutical company. Read More It develops novel antibody therapeutics for oncology targets. The company's services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.

Employees
32
Headquarters
New York, New York
Founded
2015
Market Cap
778.93M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
79.06K
High Today
$22.96
Low Today
$22.38
Open Price
$22.85
Volume
68.75K
52 Week High
$31.00
52 Week Low
$15.17

Collections

Technology
Health
Pharmaceutical
Therapy
Medical
Biopharmaceutical
Engineering
2018 IPO

YMAB Earnings

-$0.47
-$0.42
-$0.36
-$0.31
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 9, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.